APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Painkillers

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Codeine Painkillers Market Analysis and Forecast 2026-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchCodeine Painkillers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Painkillers Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Painkillers Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Painkillers Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Codeine Painkillers market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Codeine Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Codeine Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Codeine Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Codeine Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Codeine Painkillers include TEVA, Johnson & Johnson, Novartis, Viatris, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Codeine Painkillers, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Codeine Painkillers, also provides the revenue of main regions and countries. Of the upcoming market potential for Codeine Painkillers, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Codeine Painkillers revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Codeine Painkillers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Codeine Painkillers revenue, projected growth trends, production technology, application and end-user industry.

Codeine Painkillers Segment by Company

TEVA

Johnson & Johnson

Novartis

Viatris

Taiji

Sanofi Aventis

Pharmaceutical Associates

Medreich

Mallinckrodt

Lannett Company

Laboratoire Riva

Hikma

Cipla

Aristo Pharma GmbH

Apotex

Codeine Painkillers Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications Codeine

Codeine Painkillers Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Painkillers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Painkillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Codeine Painkillers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Codeine Painkillers company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine Painkillers revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Codeine Painkillers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-ingredient Codeine Major Player Table 3. Multi-ingredient Medications Codeine Major Player Table 4. Global Codeine Painkillers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Narcotic Analgesic Major Player Table 6. Antitussive Major Player Table 7. Others Major Player Table 8. Codeine Painkillers Industry Trends Table 9. Codeine Painkillers Industry Drivers Table 10. Codeine Painkillers Industry Opportunities and Challenges Table 11. Codeine Painkillers Industry Restraints Table 12. Global Codeine Painkillers Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Codeine Painkillers Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Codeine Painkillers Market Share by Region (2021-2026) Table 15. Global Codeine Painkillers Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Codeine Painkillers Market Share by Region (2027-2032) Table 17. Global Codeine Painkillers Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Codeine Painkillers Revenue Market Share by Players (2021-2026) Table 19. Global Codeine Painkillers Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Codeine Painkillers Key Players Headquarters & Area Served Table 21. Global Codeine Painkillers Players, Product Type & Application Table 22. Global Codeine Painkillers Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Codeine Painkillers by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Codeine Painkillers Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Codeine Painkillers Revenue Market Share by Type (2021-2026) Table 29. Global Codeine Painkillers Revenue Market Share by Type (2027-2032) Table 30. Global Codeine Painkillers Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Codeine Painkillers Revenue Market Share by Application (2021-2026) Table 34. Global Codeine Painkillers Revenue Market Share by Application (2027-2032) Table 35. TEVA Company Information Table 36. TEVA Business Overview Table 37. TEVA Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. TEVA Codeine Painkillers Product Portfolio Table 39. TEVA Recent Development Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson & Johnson Codeine Painkillers Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. Novartis Company Information Table 46. Novartis Business Overview Table 47. Novartis Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis Codeine Painkillers Product Portfolio Table 49. Novartis Recent Development Table 50. Viatris Company Information Table 51. Viatris Business Overview Table 52. Viatris Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Viatris Codeine Painkillers Product Portfolio Table 54. Viatris Recent Development Table 55. Taiji Company Information Table 56. Taiji Business Overview Table 57. Taiji Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Taiji Codeine Painkillers Product Portfolio Table 59. Taiji Recent Development Table 60. Sanofi Aventis Company Information Table 61. Sanofi Aventis Business Overview Table 62. Sanofi Aventis Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sanofi Aventis Codeine Painkillers Product Portfolio Table 64. Sanofi Aventis Recent Development Table 65. Pharmaceutical Associates Company Information Table 66. Pharmaceutical Associates Business Overview Table 67. Pharmaceutical Associates Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pharmaceutical Associates Codeine Painkillers Product Portfolio Table 69. Pharmaceutical Associates Recent Development Table 70. Medreich Company Information Table 71. Medreich Business Overview Table 72. Medreich Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medreich Codeine Painkillers Product Portfolio Table 74. Medreich Recent Development Table 75. Mallinckrodt Company Information Table 76. Mallinckrodt Business Overview Table 77. Mallinckrodt Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Mallinckrodt Codeine Painkillers Product Portfolio Table 79. Mallinckrodt Recent Development Table 80. Lannett Company Company Information Table 81. Lannett Company Business Overview Table 82. Lannett Company Codeine Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Lannett Company Codeine Painkillers Product Portfolio Table 84. Lannett Company Recent Development Table 85. Laboratoire Riva Company Information Table 86. Laboratoire Riva Business Overview Table 87. Laboratoire Riva Codeine Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Laboratoire Riva Codeine Painkillers Product Portfolio Table 89. Laboratoire Riva Recent Development Table 90. Hikma Company Information Table 91. Hikma Business Overview Table 92. Hikma Codeine Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Hikma Codeine Painkillers Product Portfolio Table 94. Hikma Recent Development Table 95. Cipla Company Information Table 96. Cipla Business Overview Table 97. Cipla Codeine Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Cipla Codeine Painkillers Product Portfolio Table 99. Cipla Recent Development Table 100. Aristo Pharma GmbH Company Information Table 101. Aristo Pharma GmbH Business Overview Table 102. Aristo Pharma GmbH Codeine Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Aristo Pharma GmbH Codeine Painkillers Product Portfolio Table 104. Aristo Pharma GmbH Recent Development Table 105. Apotex Company Information Table 106. Apotex Business Overview Table 107. Apotex Codeine Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Apotex Codeine Painkillers Product Portfolio Table 109. Apotex Recent Development Table 110. North America Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Codeine Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Codeine Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Codeine Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Codeine Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 124. China Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 125. China Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 126. China Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 127. China Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Codeine Painkillers Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Codeine Painkillers Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Codeine Painkillers Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Codeine Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Codeine Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Codeine Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Codeine Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Codeine Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Codeine Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Codeine Painkillers Image Figure 2. Global Codeine Painkillers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Painkillers Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-ingredient Codeine Image Figure 5. Multi-ingredient Medications Codeine Image Figure 6. Global Codeine Painkillers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Codeine Painkillers Market Size Share 2021 VS 2025 VS 2032 Figure 8. Narcotic Analgesic Image Figure 9. Antitussive Image Figure 10. Others Image Figure 11. Global Codeine Painkillers Market Size (US$ Million) & (2021-2032) Figure 12. Global Codeine Painkillers Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Codeine Painkillers Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Codeine Painkillers Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Codeine Painkillers Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Codeine Painkillers Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Codeine Painkillers Revenue Market Share by Type (2021-2032) Figure 19. Global Codeine Painkillers Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Codeine Painkillers Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Codeine Painkillers Revenue Market Share by Application (2021-2032) Figure 22. North America Codeine Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Codeine Painkillers Revenue Share by Type (2021-2032) Figure 24. North America Codeine Painkillers Revenue Share by Application (2021-2032) Figure 25. North America Codeine Painkillers Revenue Share by Country (2021-2032) Figure 26. United States Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Codeine Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Codeine Painkillers Revenue Share by Type (2021-2032) Figure 31. Europe Codeine Painkillers Revenue Share by Application (2021-2032) Figure 32. Europe Codeine Painkillers Revenue Share by Country (2021-2032) Figure 33. Germany Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Codeine Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Codeine Painkillers Revenue Share by Type (2021-2032) Figure 43. China Codeine Painkillers Revenue Share by Application (2021-2032) Figure 44. Asia Codeine Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Codeine Painkillers Revenue Share by Type (2021-2032) Figure 46. Asia Codeine Painkillers Revenue Share by Application (2021-2032) Figure 47. Asia Codeine Painkillers Revenue Share by Region (2021-2032) Figure 48. Japan Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Codeine Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Codeine Painkillers Revenue Share by Type (2021-2032) Figure 56. SAMEA Codeine Painkillers Revenue Share by Application (2021-2032) Figure 57. SAMEA Codeine Painkillers Revenue Share by Country (2021-2032) Figure 58. Brazil Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Codeine Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications Codeine
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Viatris
  • Taiji
  • Sanofi Aventis
  • Pharmaceutical Associates
  • Medreich
  • Mallinckrodt
  • Lannett Company
  • Laboratoire Riva
  • Hikma
  • Cipla
  • Aristo Pharma GmbH
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Codeine Painkillers Market by Type
  3. 1.2.1 Global Codeine Painkillers Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-ingredient Codeine
  5. 1.2.3 Multi-ingredient Medications Codeine
  6. 1.3 Codeine Painkillers Market by Application
  7. 1.3.1 Global Codeine Painkillers Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Narcotic Analgesic
  9. 1.3.3 Antitussive
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Codeine Painkillers Market Dynamics
  1. 2.1 Codeine Painkillers Industry Trends
  2. 2.2 Codeine Painkillers Industry Drivers
  3. 2.3 Codeine Painkillers Industry Opportunities and Challenges
  4. 2.4 Codeine Painkillers Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Codeine Painkillers Market Perspective (2021-2032)
  2. 3.2 Global Codeine Painkillers Growth Trends by Region
  3. 3.2.1 Global Codeine Painkillers Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Codeine Painkillers Market Size by Region (2021-2026)
  5. 3.2.3 Global Codeine Painkillers Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Codeine Painkillers Revenue by Players
  2. 4.1.1 Global Codeine Painkillers Revenue by Players (2021-2026)
  3. 4.1.2 Global Codeine Painkillers Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Codeine Painkillers Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Codeine Painkillers Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Codeine Painkillers Key Players Headquarters & Area Served
  7. 4.4 Global Codeine Painkillers Players, Product Type & Application
  8. 4.5 Global Codeine Painkillers Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Codeine Painkillers Market CR5 and HHI
  11. 4.6.3 2025 Codeine Painkillers Tier 1, Tier 2, and Tier 3
5 Codeine Painkillers Market Size by Type
  1. 5.1 Global Codeine Painkillers Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Codeine Painkillers Revenue by Type (2021-2032)
  3. 5.3 Global Codeine Painkillers Revenue Market Share by Type (2021-2032)
6 Codeine Painkillers Market Size by Application
  1. 6.1 Global Codeine Painkillers Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Codeine Painkillers Revenue by Application (2021-2032)
  3. 6.3 Global Codeine Painkillers Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 TEVA
  2. 7.1.1 TEVA Company Information
  3. 7.1.2 TEVA Business Overview
  4. 7.1.3 TEVA Codeine Painkillers Revenue and Gross Margin (2021-2026)
  5. 7.1.4 TEVA Codeine Painkillers Product Portfolio
  6. 7.1.5 TEVA Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Codeine Painkillers Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Codeine Painkillers Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Codeine Painkillers Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Codeine Painkillers Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Viatris
  20. 7.4.1 Viatris Company Information
  21. 7.4.2 Viatris Business Overview
  22. 7.4.3 Viatris Codeine Painkillers Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Viatris Codeine Painkillers Product Portfolio
  24. 7.4.5 Viatris Recent Developments
  25. 7.5 Taiji
  26. 7.5.1 Taiji Company Information
  27. 7.5.2 Taiji Business Overview
  28. 7.5.3 Taiji Codeine Painkillers Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Taiji Codeine Painkillers Product Portfolio
  30. 7.5.5 Taiji Recent Developments
  31. 7.6 Sanofi Aventis
  32. 7.6.1 Sanofi Aventis Company Information
  33. 7.6.2 Sanofi Aventis Business Overview
  34. 7.6.3 Sanofi Aventis Codeine Painkillers Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Aventis Codeine Painkillers Product Portfolio
  36. 7.6.5 Sanofi Aventis Recent Developments
  37. 7.7 Pharmaceutical Associates
  38. 7.7.1 Pharmaceutical Associates Company Information
  39. 7.7.2 Pharmaceutical Associates Business Overview
  40. 7.7.3 Pharmaceutical Associates Codeine Painkillers Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pharmaceutical Associates Codeine Painkillers Product Portfolio
  42. 7.7.5 Pharmaceutical Associates Recent Developments
  43. 7.8 Medreich
  44. 7.8.1 Medreich Company Information
  45. 7.8.2 Medreich Business Overview
  46. 7.8.3 Medreich Codeine Painkillers Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medreich Codeine Painkillers Product Portfolio
  48. 7.8.5 Medreich Recent Developments
  49. 7.9 Mallinckrodt
  50. 7.9.1 Mallinckrodt Company Information
  51. 7.9.2 Mallinckrodt Business Overview
  52. 7.9.3 Mallinckrodt Codeine Painkillers Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mallinckrodt Codeine Painkillers Product Portfolio
  54. 7.9.5 Mallinckrodt Recent Developments
  55. 7.10 Lannett Company
  56. 7.10.1 Lannett Company Company Information
  57. 7.10.2 Lannett Company Business Overview
  58. 7.10.3 Lannett Company Codeine Painkillers Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lannett Company Codeine Painkillers Product Portfolio
  60. 7.10.5 Lannett Company Recent Developments
  61. 7.11 Laboratoire Riva
  62. 7.11.1 Laboratoire Riva Company Information
  63. 7.11.2 Laboratoire Riva Business Overview
  64. 7.11.3 Laboratoire Riva Codeine Painkillers Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Laboratoire Riva Codeine Painkillers Product Portfolio
  66. 7.11.5 Laboratoire Riva Recent Developments
  67. 7.12 Hikma
  68. 7.12.1 Hikma Company Information
  69. 7.12.2 Hikma Business Overview
  70. 7.12.3 Hikma Codeine Painkillers Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Hikma Codeine Painkillers Product Portfolio
  72. 7.12.5 Hikma Recent Developments
  73. 7.13 Cipla
  74. 7.13.1 Cipla Company Information
  75. 7.13.2 Cipla Business Overview
  76. 7.13.3 Cipla Codeine Painkillers Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cipla Codeine Painkillers Product Portfolio
  78. 7.13.5 Cipla Recent Developments
  79. 7.14 Aristo Pharma GmbH
  80. 7.14.1 Aristo Pharma GmbH Company Information
  81. 7.14.2 Aristo Pharma GmbH Business Overview
  82. 7.14.3 Aristo Pharma GmbH Codeine Painkillers Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aristo Pharma GmbH Codeine Painkillers Product Portfolio
  84. 7.14.5 Aristo Pharma GmbH Recent Developments
  85. 7.15 Apotex
  86. 7.15.1 Apotex Company Information
  87. 7.15.2 Apotex Business Overview
  88. 7.15.3 Apotex Codeine Painkillers Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Apotex Codeine Painkillers Product Portfolio
  90. 7.15.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Codeine Painkillers Revenue (2021-2032)
  2. 8.2 North America Codeine Painkillers Revenue by Type (2021-2032)
  3. 8.2.1 North America Codeine Painkillers Revenue by Type (2021-2026)
  4. 8.2.2 North America Codeine Painkillers Revenue by Type (2027-2032)
  5. 8.3 North America Codeine Painkillers Revenue Share by Type (2021-2032)
  6. 8.4 North America Codeine Painkillers Revenue by Application (2021-2032)
  7. 8.4.1 North America Codeine Painkillers Revenue by Application (2021-2026)
  8. 8.4.2 North America Codeine Painkillers Revenue by Application (2027-2032)
  9. 8.5 North America Codeine Painkillers Revenue Share by Application (2021-2032)
  10. 8.6 North America Codeine Painkillers Revenue by Country
  11. 8.6.1 North America Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Codeine Painkillers Revenue by Country (2021-2026)
  13. 8.6.3 North America Codeine Painkillers Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Codeine Painkillers Revenue (2021-2032)
  2. 9.2 Europe Codeine Painkillers Revenue by Type (2021-2032)
  3. 9.2.1 Europe Codeine Painkillers Revenue by Type (2021-2026)
  4. 9.2.2 Europe Codeine Painkillers Revenue by Type (2027-2032)
  5. 9.3 Europe Codeine Painkillers Revenue Share by Type (2021-2032)
  6. 9.4 Europe Codeine Painkillers Revenue by Application (2021-2032)
  7. 9.4.1 Europe Codeine Painkillers Revenue by Application (2021-2026)
  8. 9.4.2 Europe Codeine Painkillers Revenue by Application (2027-2032)
  9. 9.5 Europe Codeine Painkillers Revenue Share by Application (2021-2032)
  10. 9.6 Europe Codeine Painkillers Revenue by Country
  11. 9.6.1 Europe Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Codeine Painkillers Revenue by Country (2021-2026)
  13. 9.6.3 Europe Codeine Painkillers Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Codeine Painkillers Revenue (2021-2032)
  2. 10.2 China Codeine Painkillers Revenue by Type (2021-2032)
  3. 10.2.1 China Codeine Painkillers Revenue by Type (2021-2026)
  4. 10.2.2 China Codeine Painkillers Revenue by Type (2027-2032)
  5. 10.3 China Codeine Painkillers Revenue Share by Type (2021-2032)
  6. 10.4 China Codeine Painkillers Revenue by Application (2021-2032)
  7. 10.4.1 China Codeine Painkillers Revenue by Application (2021-2026)
  8. 10.4.2 China Codeine Painkillers Revenue by Application (2027-2032)
  9. 10.5 China Codeine Painkillers Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Codeine Painkillers Revenue (2021-2032)
  2. 11.2 Asia Codeine Painkillers Revenue by Type (2021-2032)
  3. 11.2.1 Asia Codeine Painkillers Revenue by Type (2021-2026)
  4. 11.2.2 Asia Codeine Painkillers Revenue by Type (2027-2032)
  5. 11.3 Asia Codeine Painkillers Revenue Share by Type (2021-2032)
  6. 11.4 Asia Codeine Painkillers Revenue by Application (2021-2032)
  7. 11.4.1 Asia Codeine Painkillers Revenue by Application (2021-2026)
  8. 11.4.2 Asia Codeine Painkillers Revenue by Application (2027-2032)
  9. 11.5 Asia Codeine Painkillers Revenue Share by Application (2021-2032)
  10. 11.6 Asia Codeine Painkillers Revenue by Country
  11. 11.6.1 Asia Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Codeine Painkillers Revenue by Country (2021-2026)
  13. 11.6.3 Asia Codeine Painkillers Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Codeine Painkillers Revenue (2021-2032)
  2. 12.2 SAMEA Codeine Painkillers Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Codeine Painkillers Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Codeine Painkillers Revenue by Type (2027-2032)
  5. 12.3 SAMEA Codeine Painkillers Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Codeine Painkillers Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Codeine Painkillers Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Codeine Painkillers Revenue by Application (2027-2032)
  9. 12.5 SAMEA Codeine Painkillers Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Codeine Painkillers Revenue by Country
  11. 12.6.1 SAMEA Codeine Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Codeine Painkillers Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Codeine Painkillers Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst